Manufacturer record
Marc Lifesciences Sikkim: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
11 batches manufactured by Marc Lifesciences Sikkim (Sikkim) were declared Not of Standard Quality between October 2025 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: STS-114, Telmisartan Tablets IP 40mg (exp Apr 2027). Drugs Testing Laboratory, Chennai-06 (state lab) found it not of standard quality: Dissolution. Listed in the July 2026 alert.
Records by type
11 records linked to Marc Lifesciences Sikkim in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Telmisartan Tablets IP 40mg | Batch STS-114Mfg May 2025 · Exp Apr 2027 | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab | Jul 2026 |
| Telmisartan Tablets IP 40mg | Batch STS-124Mfg Jun 2025 · Exp May 2027 | DissolutionDissolution | DTL, Chennai-06State lab | May 2026 |
| Telmisartan Tablets IP 40mg | Batch STS-122Mfg Jun 2025 · Exp May 2027 | DissolutionDissolution | DTL,ChennaiState lab | Mar 2026 |
| Telmisartan Tablets IP 40mg | Batch STS-119Mfg May 2025 · Exp Apr 2027 | DissolutionDissolution | DTL, Chennai-06State lab | Feb 2026 |
| Telmisartan Tablets IP 40mg | Batch STS-123Mfg Jun 2025 · Exp May 2027 | Dissolution.Dissolution | DTL, Chennai-06State lab | Feb 2026 |
| Telmisartan Tablets IP 40mg | Batch STS-126Mfg Jun 2025 · Exp May 2027 | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab | Jan 2026 |
| Telmisartan Tablets IP 40 mg | Batch STS-117Mfg May 2025 · Exp Apr 2027 | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab | Jan 2026 |
| Glimpiride Tablets I.P. 2 MG. | Batch SGYT-134Mfg Mar 2025 · Exp Feb 2027 | The sample does not conform to I.P. Standard with respect to descriptive Part of the Tablet.Other | State Drugs Testing Laboratory, Kolkata, West BengalState lab | Oct 2025 |
| Glimpiride Tablets I.P. 2 MG. | Batch SGYT-120Mfg Feb 2025 · Exp Jan 2027 | The sample does not conform to I.P. Standard with respect to descriptive Part of the Tablet.Other | State Drugs Testing Laboratory, Kolkata, West BengalState lab | Oct 2025 |
| Glimpiride Tablets I.P. 2 MG. | Batch SGYT-122Mfg Feb 2025 · Exp Jan 2027 | The sample does not conform to I.P. Standard with respect to descriptive Part of the Tablet.Other | State Drugs Testing Laboratory, Kolkata, West BengalState lab | Oct 2025 |
| Glimpiride Tablets I.P. 1 MG. | Batch SLY-108Mfg Sep 2024 · Exp Aug 2026 | The sample does not conform to I.P. Standard with respect to descriptive Part of the Tablet.Other | State Drugs Testing Laboratory, Kolkata, West BengalState lab | Oct 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.